236 related articles for article (PubMed ID: 18368382)
1. New insights on signaling cascades induced by cross-talk between angiotensin II and aldosterone.
Lemarié CA; Paradis P; Schiffrin EL
J Mol Med (Berl); 2008 Jun; 86(6):673-8. PubMed ID: 18368382
[TBL] [Abstract][Full Text] [Related]
2. Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors.
Lemarié CA; Simeone SM; Nikonova A; Ebrahimian T; Deschênes ME; Coffman TM; Paradis P; Schiffrin EL
Circ Res; 2009 Oct; 105(9):852-9. PubMed ID: 19762686
[TBL] [Abstract][Full Text] [Related]
3. Cross-talk between aldosterone and angiotensin signaling in vascular smooth muscle cells.
Rautureau Y; Paradis P; Schiffrin EL
Steroids; 2011 Aug; 76(9):834-9. PubMed ID: 21371487
[TBL] [Abstract][Full Text] [Related]
4. Signaling mechanisms of angiotensin II in regulating vascular senescence.
Min LJ; Mogi M; Iwai M; Horiuchi M
Ageing Res Rev; 2009 Apr; 8(2):113-21. PubMed ID: 19162241
[TBL] [Abstract][Full Text] [Related]
5. Hypertension: renin-angiotensin-aldosterone system alterations.
Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
[TBL] [Abstract][Full Text] [Related]
6. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence.
Min LJ; Mogi M; Iwanami J; Li JM; Sakata A; Fujita T; Tsukuda K; Iwai M; Horiuchi M
Cardiovasc Res; 2007 Dec; 76(3):506-16. PubMed ID: 17706954
[TBL] [Abstract][Full Text] [Related]
7. Renal denervation attenuates aldosterone expression and associated cardiovascular pathophysiology in angiotensin II-induced hypertension.
Hong MN; Li XD; Chen DR; Ruan CC; Xu JZ; Chen J; Wu YJ; Ma Y; Zhu DL; Gao PJ
Oncotarget; 2016 Oct; 7(42):67828-67840. PubMed ID: 27661131
[TBL] [Abstract][Full Text] [Related]
8. Actions of circulating angiotensin II and aldosterone in the brain contributing to hypertension.
Leenen FH
Am J Hypertens; 2014 Aug; 27(8):1024-32. PubMed ID: 24742639
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.
Forrester SJ; Booz GW; Sigmund CD; Coffman TM; Kawai T; Rizzo V; Scalia R; Eguchi S
Physiol Rev; 2018 Jul; 98(3):1627-1738. PubMed ID: 29873596
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?
Athyros VG; Mikhailidis DP; Kakafika AI; Tziomalos K; Karagiannis A
Expert Opin Pharmacother; 2007 Apr; 8(5):529-35. PubMed ID: 17376010
[TBL] [Abstract][Full Text] [Related]
11. New aspects of rapid aldosterone signaling.
Grossmann C; Gekle M
Mol Cell Endocrinol; 2009 Sep; 308(1-2):53-62. PubMed ID: 19549592
[TBL] [Abstract][Full Text] [Related]
12. Cross-talk between mineralocorticoid and angiotensin II signaling for cardiac remodeling.
Di Zhang A; Nguyen Dinh Cat A; Soukaseum C; Escoubet B; Cherfa A; Messaoudi S; Delcayre C; Samuel JL; Jaisser F
Hypertension; 2008 Dec; 52(6):1060-7. PubMed ID: 18981328
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells.
Jaffe IZ; Mendelsohn ME
Circ Res; 2005 Apr; 96(6):643-50. PubMed ID: 15718497
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of D3 dopamine receptor on migration of vascular smooth muscle cells induced by synergistic effect of angiotensin II and aldosterone.
Li Y; Wang N; Chen C; He D; Yang J; Zeng C
Clin Exp Hypertens; 2015; 37(4):288-93. PubMed ID: 25496286
[TBL] [Abstract][Full Text] [Related]
15. Role of aldosterone and angiotensin II in insulin resistance: an update.
Lastra-Lastra G; Sowers JR; Restrepo-Erazo K; Manrique-Acevedo C; Lastra-González G
Clin Endocrinol (Oxf); 2009 Jul; 71(1):1-6. PubMed ID: 19138313
[TBL] [Abstract][Full Text] [Related]
16. A century old renin-angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology.
Balakumar P; Jagadeesh G
Cell Signal; 2014 Oct; 26(10):2147-60. PubMed ID: 25007996
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II-aldosterone interaction in human coronary microarteries involves GPR30, EGFR, and endothelial NO synthase.
Batenburg WW; Jansen PM; van den Bogaerdt AJ; J Danser AH
Cardiovasc Res; 2012 Apr; 94(1):136-43. PubMed ID: 22260839
[TBL] [Abstract][Full Text] [Related]
18. RGS2 is regulated by angiotensin II and functions as a negative feedback of aldosterone production in H295R human adrenocortical cells.
Romero DG; Plonczynski MW; Gomez-Sanchez EP; Yanes LL; Gomez-Sanchez CE
Endocrinology; 2006 Aug; 147(8):3889-97. PubMed ID: 16627589
[TBL] [Abstract][Full Text] [Related]
19. Recent Research Advances in Renin-Angiotensin-Aldosterone System Receptors.
Azushima K; Morisawa N; Tamura K; Nishiyama A
Curr Hypertens Rep; 2020 Feb; 22(3):22. PubMed ID: 32114685
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin 1-7 suppresses angiotensin II mediated aldosterone production via JAK/STAT signaling inhibition.
Itcho K; Oki K; Kobuke K; Ohno H; Yoneda M; Hattori N
J Steroid Biochem Mol Biol; 2019 Jan; 185():137-141. PubMed ID: 30125658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
